A novel indwelling subcutaneous intrathecal catheter circumvented the complex spine anatomy of patients with spinal muscular atrophy (SMA), a challenge when giving nusinersen via intrathecal injection ...
September 14, 2012 — The US Food and Drug Administration (FDA) has approved a new catheter (Ascenda, Medtronic Inc) for use in the delivery of intrathecal baclofen (ITB) therapy. According to the ...
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has classified its safety alert about the proper connection of sutureless ...
July 24, 2006 — The US Food and Drug Administration (FDA) and Medtronic, Inc, have warned healthcare professionals via letter regarding the worldwide voluntary recall of nonimplanted intrathecal ...
A study presented at the 2011 annual meeting of the Society of Obstetric Anesthesia and Perinatology found that women undergoing C-sections may require a smaller dose of anesthesia when administered ...
LOWELL, Mass., Jan. 3, 2024 /PRNewswire/ -- Alcyone Therapeutics Inc. (Alcyone), a biotechnology company pioneering next-generation precision genetic therapies and precision delivery solutions of ...
STRASBURG, PA – A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease. SMA ...
Intrathecal drug delivery involves administering analgesic medications directly into the cerebrospinal fluid, thereby achieving targeted pain relief while minimising systemic side effects. This method ...
CHICAGO (Reuters) - Medtronic Inc said on Friday that U.S. health regulators classified its safety alert about the proper connection of sutureless catheters used with implantable drug infusion systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results